Tick-borne encephalitis virus (TBEV) encodes a conserved, immunogenic, non-structural protein NS1 that is glycosylated and secreted from infected cells in an oligomeric form. An adenovirus recombinant, RAd51, expressing high levels of TBEV NS1 has previously been demonstrated to protect mice against a lethal challenge with TBEV. We show here that BALB/c mice infected with TBEV experienced a transient viraemia between days 3 to 5 post-inoculation that was detectable prior to the encephalitic phase of infection. Mice vaccinated with RAd51 were protected against both the viraemic and encephalitic infections associated with the TBEV challenge. Protection was demonstrated to be due to NS1 synthesized de novo from RAd51 in the vaccinated mice. Since TBEV NS1 is expressed on the cell surface, antibody-dependent complement-mediated cytolysis (CMC) of infected cells was considered as a possible mechanism of protection. Vaccination with the recombinant adenovirus proved to be effective in a mouse strain carrying a genetic deletion in the complement receptor C5. CMC is therefore not an essential component of the observed protective immune response.
BarrettA. D. T., GouldE. A.1986; Antibody-mediated early death in vivo after infection with yellow fever virus. Journal of General Virology 67:2539–2542
CalisherC. H., KarabatsosN., DalrympleJ. M., ShopeR. E., PorterfieldJ. S., WestawayE. G., BrandtW. E.1989; Antigenic relationships between flaviviruses as determined by cross�neutralization test with polyclonal antisera. Journal of General Virology 70:37–43
GouldE. A., BuckleyA., BarrettA. D. T., CammackN.1986; Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. Journal of General Virology 67:591–595
GouldE. A., BuckleyA., GroegerB. K., CaneP. A., DoenhoffM.1987; Immune enhancement of yellow fever virus neurovirulence for mice: studies of mechanisms involved. Journal of General Virology 68:3105–3112
HawkesR. A.1964; Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls. Australian Journal of Biological Sciences 42:465–482
HeinzF. X., KunzC.1981; Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses. Journal of General Virology 57:263–274
JacobsS. C., StephensonJ. R., WilkinsonG. W. G.1992; High level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. Journal of Virology 66:2086–2095
KayserM., KleinH., PaaschI., PilaskiJ., BlenkH., HeegK.1985; Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine. Journal of Medical Virology 17:35–45
PhillpottsR. J., StephensonJ. R., PorterfieldJ. S.1985; Antibody-dependent enhancement of tick-borne encephalitis virus infectivity. Journal of General Virology 66:1831–1837
PreciousB., RussellW. C.1985; Growth, purification and tritration of adenoviruses. In Virology: A Practical Approach pp 193–205MahyB. W. J. Edited by Oxford: IRL Press;
SchlesingerJ. J., BrandrissM. W., WalshE. E.1985; .Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the non-structural glycoprotein gp48 and by active immunization with Gp48. Journal of Immunology 135:2805–2809
SchlesingerJ. J., BrandrissM. W., CroppC. B., MonathT. P.1986; Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. Journal of Virology 60:1153–1155
SchlesingerJ. J., BrandrissM. W., WalshE. E.1987; Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. Journal of General Virology 68:853–857
SchlesingerJ. J., FoltzerM., ChapmanS.1993; The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 192:132–141
StephensonJ. R., LeeJ. M., Wilton-SmithP. D.1984; Antigenic variation among members of the tick-borne encephalitis complex. Journal of General Virology 65:81–89
WilkinsonG. W. G., AkriggA.1992; Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Research 20:2233–2239